You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 91 No. 6, JUNE 1953 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

IDIOPATHIC ULCERATIVE COLITIS

Giant Ulceration Following Corticotropin (ACTH) and Cortisone Therapy

E. C. TEXTER, Jr., M.D.; C. W. LEGERTON, Jr., M.D.; J. M. RUFFIN, M.D.; J. A. BOYD, Jr., M.D.; A. G. SMITH, M.D.

AMA Arch Intern Med. 1953;91(6):744-757.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE USE of corticotropin (ACTH) for patients with severe ulcerative colitis usually is accompanied by striking subjective improvement. Objective evidence of healing, however, has not been noted as frequently, and adverse effects including activation of peptic ulcers and perforation of the colon have been reported.1

This report is based upon observations made on 14 patients having severe or fulminating ulcerative colitis who were treated with intravenous corticotropin at Duke Hospital and on one other patient who was treated elsewhere. Five of these patients subsequently were operated upon, four having a colectomy and the fifth an ileostomy only. Large atypical undermined ulcers were present throughout the colon and rectum in the four patients in whom colectomy was done.

CLINICAL MATERIAL AND METHODS

The clinical data on the 15 patients who received corticoid therapy are shown in the Table. The clinical course of the disease prior to treatment was classified as . . . [Full Text PDF of this Article]


Author Affiliations

CHICAGO; CONWAY, S. C.; DURHAM, N. C.

From the Departments of Medicine, Radiology, and Pathology, Duke University School of Medicine, Durham, N. C. Dr. Texter's present address is Department of Medicine, Northwestern University Medical School, Chicago 11.


Footnotes

Dr. David Klein, Wilson Laboratories, Chicago, provided corticotropin and corticotropin gel and Dr. Elmer Alpert, Merck & Company, Rahway, N. J., provided the cortisone (Cortone) acetate used in the treatment of certain of the patients, which was made available through Dr. F. L. Engle, Duke Hospital.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1953 American Medical Association. All Rights Reserved.